HTX-019 is a proprietary IV injectable emulsion formulation designed to directly deliver aprepitant, a substance P/NK1 receptor antagonist, as a 30-second IV injection.
Investigators assessed the safety and efficacy of somatostatin analogue therapy on red blood cell transfusion requirements in patients with gastrointestinal angiodysplasias.
Investigators assessed the association between diet quality and risk for and severity of COVID-19, as well as its relationship with socioeconomic deprivation.
Researchers sought to assess the risk for COVID-19-related hospitalization or death among patients with immune-mediated inflammatory diseases receiving treatment with tumor necrosis factor inhibitors.
People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.
For adults aged 65 years and older, sepsis-related death rates declined from 2000 through 2019, with higher rates among older adults, among non-Hispanic Blacks, and in rural areas.
For adults with chronic pain conditions receiving long-term opioid therapy, a cognitive behavioral therapy (CBT) intervention produces modest, but sustained, reductions in measures of pain and pain-related disability.
Investigators conducted a study to determine the optimal management of drug-resistant cytomegalovirus in 2 patients who previously underwent stem cell and kidney transplantation.
Investigators conducted a study that compared the risk for intubation or death with convalescent plasma vs standard care for the treatment of patients hospitalized with COVID-19.
